These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 23642142
1. Interaction between platinum complexes and the C-terminal motif of human copper transporter 1. Wang E, Xi Z, Li Y, Li L, Zhao L, Ma G, Liu Y. Inorg Chem; 2013 May 20; 52(10):6153-9. PubMed ID: 23642142 [Abstract] [Full Text] [Related]
2. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex. Wu X, Yuan S, Wang E, Tong Y, Ma G, Wei K, Liu Y. Metallomics; 2017 May 24; 9(5):546-555. PubMed ID: 28383086 [Abstract] [Full Text] [Related]
3. The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex. Ma G, Wu Q, Wu X, Arnesano F, Natile G, Sletten E, Liu Y. J Inorg Biochem; 2015 Dec 24; 153():239-246. PubMed ID: 26235215 [Abstract] [Full Text] [Related]
4. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1. Wu Z, Liu Q, Liang X, Yang X, Wang N, Wang X, Sun H, Lu Y, Guo Z. J Biol Inorg Chem; 2009 Nov 24; 14(8):1313-23. PubMed ID: 19669174 [Abstract] [Full Text] [Related]
5. Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1. Crider SE, Holbrook RJ, Franz KJ. Metallomics; 2010 Jan 24; 2(1):74-83. PubMed ID: 21072377 [Abstract] [Full Text] [Related]
6. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT. Mol Cancer Ther; 2004 Dec 24; 3(12):1543-9. PubMed ID: 15634647 [Abstract] [Full Text] [Related]
7. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1). Du X, Wang X, Li H, Sun H. Metallomics; 2012 Jul 24; 4(7):679-85. PubMed ID: 22552365 [Abstract] [Full Text] [Related]
8. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes. Xi Z, Guo W, Tian C, Wang F, Liu Y. Metallomics; 2014 Mar 24; 6(3):491-7. PubMed ID: 24469739 [Abstract] [Full Text] [Related]
9. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R, Howell SB. Mol Pharmacol; 2004 Oct 24; 66(4):817-23. PubMed ID: 15229296 [Abstract] [Full Text] [Related]
10. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters. Guo Y, Smith K, Petris MJ. J Biol Chem; 2004 Nov 05; 279(45):46393-9. PubMed ID: 15326162 [Abstract] [Full Text] [Related]
11. Probing the interaction of cisplatin with the human copper chaperone Atox1 by solution and in-cell NMR spectroscopy. Arnesano F, Banci L, Bertini I, Felli IC, Losacco M, Natile G. J Am Chem Soc; 2011 Nov 16; 133(45):18361-9. PubMed ID: 21981264 [Abstract] [Full Text] [Related]
12. Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B. Tadini-Buoninsegni F, Bartolommei G, Moncelli MR, Inesi G, Galliani A, Sinisi M, Losacco M, Natile G, Arnesano F. Angew Chem Int Ed Engl; 2014 Jan 27; 53(5):1297-301. PubMed ID: 24375922 [Abstract] [Full Text] [Related]
13. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V. Biochemistry; 2003 May 27; 42(20):6321-32. PubMed ID: 12755637 [Abstract] [Full Text] [Related]
14. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Kane SA, Lippard SJ. Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559 [Abstract] [Full Text] [Related]
15. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells. Ivy KD, Kaplan JH. Mol Pharmacol; 2013 Jun 20; 83(6):1237-46. PubMed ID: 23543413 [Abstract] [Full Text] [Related]
16. Interaction between platinum complexes and a methionine motif found in copper transport proteins. Arnesano F, Scintilla S, Natile G. Angew Chem Int Ed Engl; 2007 Jun 20; 46(47):9062-4. PubMed ID: 17886318 [No Abstract] [Full Text] [Related]
17. Cisplatin mediates selective downstream hydrolytic cleavage of Met-(Gly)(n)-His segments (n=1,2) in methionine- and histidine-containing peptides: the role of ammine loss trans to the initial Pt-S(Met) anchor in facilitating amide hydrolysis. Hohage O, Sheldrick WS. J Inorg Biochem; 2006 Sep 20; 100(9):1506-13. PubMed ID: 16806482 [Abstract] [Full Text] [Related]
18. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme. Casini A, Mastrobuoni G, Temperini C, Gabbiani C, Francese S, Moneti G, Supuran CT, Scozzafava A, Messori L. Chem Commun (Camb); 2007 Jan 14; (2):156-8. PubMed ID: 17180231 [Abstract] [Full Text] [Related]
19. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs. Ravera M, Gabano E, Zanellato I, Bonarrigo I, Alessio M, Arnesano F, Galliani A, Natile G, Osella D. J Inorg Biochem; 2015 Sep 14; 150():1-8. PubMed ID: 26042542 [Abstract] [Full Text] [Related]
20. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group. Mandal R, Kalke R, Li XF. Chem Res Toxicol; 2004 Oct 14; 17(10):1391-7. PubMed ID: 15487901 [Abstract] [Full Text] [Related] Page: [Next] [New Search]